相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice
Katerina I. Leonova et al.
CELL CYCLE (2010)
Structure-Specific Recognition Protein 1 Facilitates Microtubule Growth and Bundling Required for Mitosis
Shelya X. Zeng et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Functional cooperation between FACT and MCM is coordinated with cell cycle and differential complex formation
Bertrand Chin-Ming Tan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Han-Ming Shen et al.
APOPTOSIS (2009)
Impaired DNA damage response - An Achilles' heel sensitizing cancer to chemotherapy and radiotherapy
Zbigniew Darzynkiewicz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells
Susanne Burdak-Rothkamm et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents
Katerina Gurova
FUTURE ONCOLOGY (2009)
Phosphorylated Intrinsically Disordered Region of FACT Masks Its Nucleosomal DNA Binding Elements
Yasuo Tsunaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Role for SSRP1 in Recombination-Mediated DNA Damage Response
Anuradha Kumari et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
DNA-Dependent Protein Kinase (DNA-PK)-Dependent Cisplatin-Induced Loss of Nucleolar Facilitator of Chromatin Transcription (FACT) and Regulation of Cisplatin Sensitivity by DNA-PK and FACT
Janna Dejmek et al.
MOLECULAR CANCER RESEARCH (2009)
9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways
C. Guo et al.
ONCOGENE (2009)
Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation
Amit Kulkarni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells
Kyung-Jin Jung et al.
JOURNAL OF VIROLOGY (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays
Michael E. Hudson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Assessment of atypical DNA intercalating agents in biological and in silico systems
Ronald D. Snyder
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Upregulation of Twist-1 by NF-κB blocks cytotoxicity induced by chemotherapeutic drugs
Can G. Pham et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Extraction, purification and analysis of histones
David Shechter et al.
NATURE PROTOCOLS (2007)
A gene-specific requirement for FACT during transcription is related to the chromatin organization of the transcribed region
Silvia Jimeno-Gonzalez et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Functional cooperation between FACT and MCM helicase facilitates initiation of chromatin DNA replication
Bertrand Chin-Ming Tan et al.
EMBO JOURNAL (2006)
de FACTo nucleosome dynamics
Danny Reinberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors
KV Gurova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Toward a greater appreciation of noncovalent chemical/DNA interactions: Application of biological and computational approaches
RD Snyder et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2005)
Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients
FLA Fonseca et al.
BREAST CANCER RESEARCH (2005)
p53 pathway in renal cell carcinoma is repressed by a dominant mechanism
KV Gurova et al.
CANCER RESEARCH (2004)
The FACT chromatin modulator: genetic and structure/function relationships
RA Singer et al.
BIOCHEMISTRY AND CELL BIOLOGY (2004)
FACT facilitates transcription-dependent nucleosome alteration
R Belotserkovskaya et al.
SCIENCE (2003)
The initiation-elongation transition: Lateral mobility of RNA in RNA polymerase II complexes is greatly reduced at+8/+9 and absent by+23
M Pal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
P53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2•hSPT16•SSRP1 complex
DM Keller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Promoter clearance by RNA polymerase II is an extended, multistep process strongly affected by sequence
M Pal et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin
AT Yarnell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
A Ito et al.
EMBO JOURNAL (2001)
A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1
DM Keller et al.
MOLECULAR CELL (2001)
Overexpression of the wild-type p53 gene inhibits NF-κB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells
J Shao et al.
ONCOGENE (2000)
Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation
M Kapoor et al.
ONCOGENE (2000)
分享论文
